Pharmaceutical medicines and services in India.
Annual revenue $115,851 Latest available
Total funding - Funding intelligence
Employees 10 Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Asprant

Asprant is a company. The company has 10 employees as of March 28, 2024. Asprant offers products and services including Afelon Medicine and Asphen-650 Medicine.

Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $115.85 K (USD)
    -33.43
    as on Mar 31, 2023
  • Net Profit
    -$27.43 K (USD)
    -306.24
    as on Mar 31, 2023
  • EBITDA
    $7.53 K (USD)
    -81.34
    as on Mar 31, 2023
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    10

    as on Mar 28, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Asprant

Asprant offers a comprehensive portfolio of products and services, including Afelon Medicine and Asphen-650 Medicine.

Product name locked
Category locked
Primary

Afelon Medicine is offered as a pharmaceutical product for health applications.

Product name locked
Category locked
Locked

Asphen-650 Medicine is provided as a medicinal solution for specific health needs.

Funding Insights of Asprant

Premium access

Detailed funding history for Asprant

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Asprant

Investments
Premium access

Investment portfolio details for Asprant

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Asprant

Premium access

Detailed financials for Asprant

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Asprant Comparisons

Asprant Primary company
Description
Pharmaceutical medicines and services in India.
Location
-
Founded Year
-
Annual Revenue
$115.85 K (USD)
Net Profit
-$27.43 K (USD)
EBITDA
$7.53 K (USD)
Employees
10
As of 2024
Premium access

Peer comparison for Asprant

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Asprant

Premium access

Detailed competitors of Asprant

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Asprant

Premium access

Complete news archive for Asprant

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Asprant

As of Mar 28, 2024, the latest employee count at Asprant is 10.

Annual revenue of Asprant is $115.85K as on Mar 31, 2023.

Asprant Life Science Private Limited is recognized as a private company that was incorporated on 24 May 2018 in Kolkata, West Bengal. It is classified as a key entity in the pharmaceutical sector, where various medicines such as Afelon and Asphen-650 are offered. The company is managed by directors including Sutapa Chakraborty and is governed by principles of innovation and integrity. Its mission emphasizes the provision of high-quality products that contribute positively to communities and stakeholders, with a commitment to sustainability and ethical practices. Operations are supported by regional offices in Guwahati and Cuttack, ensuring wider reach.

Asprant offers Afelon Medicine and Asphen-650 Medicine.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available